医学
心脏再同步化治疗
左束支阻滞
心力衰竭
心脏病学
内科学
观察研究
QRS波群
除颤
冠状窦
心动过缓
随机对照试验
心脏起搏
心肌病
重症监护医学
临床实习
心室不同步
束支阻滞
心脏传导系统
心电图
射血分数
循证医学
窦性心动过缓
捆绑
心室颤动
植入式心律转复除颤器
心房颤动
临床试验
作者
Georgios Leventopoulos,Rafail Koros,Michael Derndorfer,Kassiani-Maria Nastouli,Angelos Perperis,Martin Martinek,Maria Bozika,Efthimia Kapsali,Ioanna C. Koniari,Periklis A. Davlouros,Helmut Pürerfellner,Γεώργιος Κόλλιας
标识
DOI:10.1016/j.hjc.2026.09.003
摘要
Conventional right ventricular pacing (RVP) is associated with electromechanical dyssynchrony and may contribute to pacing-induced cardiomyopathy (PICM). Left bundle branch area pacing (LBBAP) has emerged as a physiological pacing strategy that engages the native conduction system. This review summarizes the current clinical evidence and future perspectives for LBBAP in both bradycardia and heart failure indications. LBBAP has been associated with improved electrical synchrony, preservation of left ventricular function, and lower rates of heart failure hospitalization and mortality compared with conventional RVP in bradyarrhythmias, although much of the evidence supporting these clinical outcomes is derived from observational studies and registries, while randomized evidence remains limited. In patients with heart failure and indications for cardiac resynchronization therapy (CRT), LBBAP has demonstrated greater QRS narrowing and favorable echocardiographic responses compared with biventricular pacing (BiVP). However, whether these physiological and echocardiographic advantages translate into superior long-term clinical outcomes remains uncertain. For patients with advanced heart failure or diffuse conduction system disease, hybrid resynchronization strategies, such as left bundle branch-optimized cardiac resynchronization therapy (LOT-CRT), combine LBBAP with coronary sinus lead pacing and may provide additional opportunities for individualized resynchronization, although their incremental clinical benefit requires further investigation. The current article outlines LBBAP capture definitions, implantation equipment, and standard electrocardiographic (ECG) capture criteria and reviews evidence from randomized clinical trials, observational studies, and registries, including specific clinical scenarios such as pacing after transcatheter aortic valve replacement (TAVR) and pace-and-ablate approaches, as well as early experience with integrated defibrillation leads. Current limitations and gaps in the evidence are also highlighted.
科研通智能强力驱动
Strongly Powered by AbleSci AI